Literature DB >> 16908557

Temporal horn index and volume of medial temporal lobe atrophy using a new semiautomated method for rapid and precise assessment.

F L Giesel1, H K Hahn, P A Thomann, E Widjaja, E Wignall, H von Tengg-Kobligk, J Pantel, P D Griffiths, H O Peitgen, J Schroder, M Essig.   

Abstract

BACKGROUND AND
PURPOSE: Quantitative markers of Alzheimer disease (AD), particularly in the early stages, are needed for clinical assessment and monitoring. We have evaluated a novel method to segment and visualize the ventricular system and obtain volumetric measures thereof. The temporal horn volume (THV) and index in patients with mild cognitive impairment (MCI) and in those with AD were evaluated.
METHODS: High-resolution T1-weighted volume imaging was performed in 52 subjects (21 patients with MCI, 10 with AD, and 21 healthy control subjects). An interactive watershed transformation and semiautomated histogram analysis were implemented to produce segmented THV and temporal horn indices (THI) (ratio of THV to lateral ventricular volume).
RESULTS: Cerebral ventricular and temporal horn size could be semiautomatically quantified from all 52 datasets. The method was fast and rater-independent. Qualitative ventricular inspections using surface rendering shading could uncover atrophic process with enlargement of the whole and especially temporal horn volume. Both THV and THI of patients with AD were significantly larger than those of patients with MCI or control subjects (P < .005). There was no significant difference in THV and THI between patients with MCI or control subjects (P > .05). There was a significant correlation between the neuropsychologic performance and both THI and THV across groups (P < .01).
CONCLUSION: THV and THI could be used as markers of AD in the clinical environment and are expected to be helpful in monitoring therapeutic intervention.

Entities:  

Mesh:

Year:  2006        PMID: 16908557      PMCID: PMC7977513     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  34 in total

1.  MRI as a biomarker of disease progression in a therapeutic trial of milameline for AD.

Authors:  C R Jack; M Slomkowski; S Gracon; T M Hoover; J P Felmlee; K Stewart; Y Xu; M Shiung; P C O'Brien; R Cha; D Knopman; R C Petersen
Journal:  Neurology       Date:  2003-01-28       Impact factor: 9.910

Review 2.  MR-based in vivo hippocampal volumetrics: 1. Review of methodologies currently employed.

Authors:  E Geuze; E Vermetten; J D Bremner
Journal:  Mol Psychiatry       Date:  2005-02       Impact factor: 15.992

3.  Rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease.

Authors:  C R Jack; R C Petersen; Y Xu; P C O'Brien; G E Smith; R J Ivnik; E G Tangalos; E Kokmen
Journal:  Neurology       Date:  1998-10       Impact factor: 9.910

4.  Radial width of the temporal horn: a sensitive measure in Alzheimer disease.

Authors:  Giovanni B Frisoni; Cristina Geroldi; Alberto Beltramello; Angelo Bianchetti; Giuliano Binetti; Giovanni Bordiga; Charles DeCarli; Mikko P Laakso; Hilkka Soininen; Cristina Testa; Orazio Zanetti; Marco Trabucchi
Journal:  AJNR Am J Neuroradiol       Date:  2002-01       Impact factor: 3.825

5.  Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease.

Authors:  C R Jack; R C Petersen; Y C Xu; S C Waring; P C O'Brien; E G Tangalos; G E Smith; R J Ivnik; E Kokmen
Journal:  Neurology       Date:  1997-09       Impact factor: 9.910

Review 6.  Use of structural imaging to study the progression of Alzheimer's disease.

Authors:  A D Smith; K A Jobst
Journal:  Br Med Bull       Date:  1996-07       Impact factor: 4.291

7.  The progression of Alzheimer's disease from limbic regions to the neocortex: clinical, radiological and pathological relationships.

Authors:  Z Nagy; N J Hindley; H Braak; E Braak; D M Yilmazer-Hanke; C Schultz; L Barnetson; E M King; K A Jobst; A D Smith
Journal:  Dement Geriatr Cogn Disord       Date:  1999 Mar-Apr       Impact factor: 2.959

8.  Clinicopathologic correlates in Alzheimer disease: assessment of clinical and pathologic diagnostic criteria.

Authors:  A M Kazee; T A Eskin; L W Lapham; K R Gabriel; K D McDaniel; R W Hamill
Journal:  Alzheimer Dis Assoc Disord       Date:  1993       Impact factor: 2.703

Review 9.  Neuroimaging and early diagnosis of Alzheimer disease: a look to the future.

Authors:  Jeffrey R Petrella; R Edward Coleman; P Murali Doraiswamy
Journal:  Radiology       Date:  2003-02       Impact factor: 11.105

10.  Linear measures of atrophy in mild Alzheimer disease.

Authors:  G B Frisoni; A Beltramello; C Weiss; C Geroldi; A Bianchetti; M Trabucchi
Journal:  AJNR Am J Neuroradiol       Date:  1996-05       Impact factor: 3.825

View more
  12 in total

1.  Automated MR morphometry to predict Alzheimer's disease in mild cognitive impairment.

Authors:  Klaus H Fritzsche; Bram Stieltjes; Sarah Schlindwein; Thomas van Bruggen; Marco Essig; Hans-Peter Meinzer
Journal:  Int J Comput Assist Radiol Surg       Date:  2010-05-04       Impact factor: 2.924

2.  Accuracy and reproducibility of a novel semi-automatic segmentation technique for MR volumetry of the pituitary gland.

Authors:  Diane M Renz; Horst K Hahn; Peter Schmidt; Jan Rexilius; Markus Lentschig; Alexander Pfeil; Dieter Sauner; Clemens Fitzek; Hans-Joachim Mentzel; Werner A Kaiser; Jürgen R Reichenbach; Joachim Böttcher
Journal:  Neuroradiology       Date:  2010-06-19       Impact factor: 2.804

3.  Z-score-based semi-quantitative analysis of the volume of the temporal horn of the lateral ventricle on brain CT images.

Authors:  Noriyuki Takahashi; Toshibumi Kinoshita; Tomomi Ohmura; Yongbum Lee; Eri Matsuyama; Hideto Toyoshima; Du-Yih Tsai
Journal:  Radiol Phys Technol       Date:  2015-09-24

4.  Cardiac index is associated with brain aging: the Framingham Heart Study.

Authors:  Angela L Jefferson; Jayandra J Himali; Alexa S Beiser; Rhoda Au; Joseph M Massaro; Sudha Seshadri; Philimon Gona; Carol J Salton; Charles DeCarli; Christopher J O'Donnell; Emelia J Benjamin; Philip A Wolf; Warren J Manning
Journal:  Circulation       Date:  2010-08-02       Impact factor: 29.690

5.  Influence of brain-derived neurotrophic factor and apolipoprotein E genetic variants on hemispheric and lateral ventricular volume of young healthy adults.

Authors:  Christos Sidiropoulos; Kourosh Jafari-Khouzani; Hamid Soltanian-Zadeh; Panayiotis Mitsias; Panagiotis Alexopoulos; Tanja Richter-Schmidinger; Martin Reichel; Piotr Lewczuk; Arnd Doerfler; Johannes Kornhuber
Journal:  Acta Neuropsychiatr       Date:  2011-06       Impact factor: 3.403

6.  Ventricular enlargement as a possible measure of Alzheimer's disease progression validated using the Alzheimer's disease neuroimaging initiative database.

Authors:  Sean M Nestor; Raul Rupsingh; Michael Borrie; Matthew Smith; Vittorio Accomazzi; Jennie L Wells; Jennifer Fogarty; Robert Bartha
Journal:  Brain       Date:  2008-07-11       Impact factor: 13.501

7.  High-throughput, fully automated volumetry for prediction of MMSE and CDR decline in mild cognitive impairment.

Authors:  Sanja Kovacevic; Michael S Rafii; James B Brewer
Journal:  Alzheimer Dis Assoc Disord       Date:  2009 Apr-Jun       Impact factor: 2.703

8.  Cortical and Subcortical Grey and White Matter Atrophy in Myotonic Dystrophies Type 1 and 2 Is Associated with Cognitive Impairment, Depression and Daytime Sleepiness.

Authors:  Christiane Schneider-Gold; Barabara Bellenberg; Christian Prehn; Christos Krogias; Ruth Schneider; Jan Klein; Ralf Gold; Carsten Lukas
Journal:  PLoS One       Date:  2015-06-26       Impact factor: 3.240

9.  MTA index: a simple 2D-method for assessing atrophy of the medial temporal lobe using clinically available neuroimaging.

Authors:  Manuel Menéndez-González; Alfonso López-Muñiz; José A Vega; José M Salas-Pacheco; Oscar Arias-Carrión
Journal:  Front Aging Neurosci       Date:  2014-03-24       Impact factor: 5.750

10.  Dementia in Down's syndrome: an MRI comparison with Alzheimer's disease in the general population.

Authors:  Diane Mullins; Eileen Daly; Andrew Simmons; Felix Beacher; Catherine Ml Foy; Simon Lovestone; Brian Hallahan; Kieran C Murphy; Declan G Murphy
Journal:  J Neurodev Disord       Date:  2013-08-20       Impact factor: 4.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.